- Email: admin@lab2mkt.com
- Call Now: (949) 979-5311
We coach biomedical innovators that want to commercialize their technology.
The LAB2MARKET3Ci program is designed to provide innovators with the specialized business framework and essential tools for successful translation of biomedical technologies from lab to market.
The Lab2Market3CI, a 24-week intensive program, will provide you with a step-by-step roadmap for how to take your project from lab to market. As you progress through the program, you will be able to critically self-reflect on the following questions:
Our vision at LAB2MARKET3Ci is to be the global leader in empowering biomedical innovators and catalyzing the seamless transition of their groundbreaking technologies from laboratory discoveries to transformative market solutions.
In pursuit of this vision, we envision a future where: Biomedical Innovation Thrives, Impactful Solution Abound, Collaborative Ecosystems Flourish, Sustainable Entrepreneurship Prevails, and Global Health is Transformed.
As we relentlessly pursue our mission, we are driven by this inspiring vision, knowing that our efforts today will lay the foundation for a healthier, more innovative, and interconnected world tomorrow.
At LAB2MARKET3Ci, our mission is to empower biomedical innovators with the knowledge, skills, and resources they need to transform their cutting-edge technologies into successful commercial ventures. We are dedicated to bridging the gap between the laboratory and the market, guiding passionate innovators on their journey towards making a tangible impact on healthcare and society.
By fostering a culture of innovation, entrepreneurship, and collaboration, we aim to catalyze groundbreaking advancements in the biomedical field. LAB2MARKET3Ci is committed to supporting visionary innovators in their pursuit of bringing life-changing technologies to the world, creating a brighter and healthier future for all.
The program commences in Phase 1, focusing on the validation of the Unmet Need among participants. This phase entails the exploration of key Stakeholders’ Value Proposition and Product attributes, which have the potential to reshape medical practices upon adoption. Once a significant Unmet Need is substantiated, the participants then delve into assessing the product’s capacity to secure the essential funding required for market entry—a critical facet we refer to as Business viability.
Phase 2 encompasses a comprehensive exploration of all aspects related to commercialization. This phase involves diving into areas such as Key Experiments, Regulatory and Reimbursement strategies, Intellectual Property considerations, Scale-Up Manufacturing, Sales and Marketing strategies, Competition analysis, milestone delineation, timeline planning, and funding requisites essential for successfully navigating the path to market entry.
Each participating team is paired with a dedicated Senior Business Advisor and a Program Manager who conduct weekly virtual meetings to guide the teams through the various activities required to prepare a compelling Venture Capital (VC) pitch. Towards the program’s conclusion, teams undergo rigorous pitch practice sessions with the invaluable support of expert coaches.
Throughout the program’s duration, teams have multiple opportunities to present their projects to a panel of esteemed Senior Business Advisors, each bringing a diverse array of perspectives to enrich the development process.
Additionally, teams participate in an initial Virtual Kickoff Meeting, followed by an in-person, intensive 2 1/2-day meeting. The program culminates with a final presentation, akin to a VC pitch, where teams showcase their innovative biomedical solutions to potential stakeholders and investors.
Our team of C-level professionals and project managers with extensive experience in bringing medical devices, diagnostic, biotech, and life science products to market. Our team has trained and supported hundreds of university teams and early- stage companies wishing to commercialize their biomedical innovations.
